Upifitamab

Upifitamab is an ADC Antibody (a naked antibody of upifitamab rilsodotin), which can be used for antibody-coupled agent (ADC) synthesis. Upifitamab rilsodotin is an ADC targeting NaPi2b and is used in ovarian cancer research, particularly in platinum-resistant recurrent ovarian cancer.
Read more
€0.00 (tax incl.)
Reference:
HY-P99229
Product Details
HY-P99229

Data sheet

Size
Multiple sizes
Reactivity
ADC Antibody
Application
Cancer-programmed cell death
CAS
2254118-43-7

Menu

Settings